Randomized Trialhigh evidence
Gut microbiome predicts personalized responses to dietary fiber in prediabetes: a randomized, open-label trial.
Nature communications·December 13, 2025·PMID 41390484
Why it mattersPrediabetes management often relies on uniform dietary advice, but response to fiber is heterogeneous. This study demonstrates that gut microbiome composition can identify individuals likely to achieve glycemic benefit from fiber, supporting a precision nutrition approach.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled